Robert J. Moots

Edge Hill University — United Kingdom

Medicine · Health Sciences

66h-index15.3kcitations327works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(95), Systemic Lupus Erythematosus Research(47), Ocular Diseases and Behçet’s Syndrome(45), Autoimmune and Inflammatory Disorders Research(32), Spondyloarthritis Studies and Treatments(30)

Publications318 total

Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis
Rheumatology and Therapy·2026Open Access
Les perspectives des rhumatologues européens sur les potentielles futures utilisations des inhibiteurs de Janus kinase (JAKi) dans les maladies rhumatismales et musculo-squelettiques (RMS) : une étude Delphi
Revue du Rhumatisme·2025
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025
Lara D. Veeken·2025Open Access
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025
British Journal of Dermatology·2025Open Access
Developing Rheumatology in Sub-Saharan Africa: Addressing the Challenges
The Journal of Rheumatology·2025Open Access
ABS0046 THE EVOLVING ROLE OF JANUS KINASE INHIBITORS (JAKI) IN RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDS): AN INTERNATIONAL DELPHI STUDY
Annals of the Rheumatic Diseases·2025Open Access
Predicting response to infliximab and interferon-α in Behçet’s syndrome: An exploratory analysis from the BIO-BEHÇET’S randomized controlled trial
Rheumatology and Immunology Research·2025Open Access
ABS0059 THE PERSPECTIVES OF EUROPEAN RHEUMATOLOGISTS ON THE POTENTIAL FUTURE OF JANUS KINASE INHIBITOR (JAKI) USE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDS): A DELPHI STUDY
Annals of the Rheumatic Diseases·2025Open Access
Enhance the transparency in the development of the British Association of Dermatologists' living guidelines: reply from authors
British Journal of Dermatology·2025
P190 An international modified Delphi study to understand clinical opinion on current and potential future use of Janus kinase inhibitors in rheumatic and musculoskeletal diseases: global results
Lara D. Veeken·2025Open Access
Assessment of IL-6 Pathway Inhibition in Gastrointestinal Behçet’s Disease from Immunological and Clinical Perspectives
Biomedicines·2025· 1 citedOpen Access
Janus-kinase inhibitor use in immune-mediated inflammatory diseases beyond licensed indications: A scoping review
Autoimmunity Reviews·2024· 1 citedOpen Access
The potential for biosimilars to address unmet clinical need — Is the developed world missing out?
Rheumatology and Immunology Research·2024· 1 citedOpen Access
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study
Arthritis & Rheumatology·2024· 9 citedOpen Access
Infliximab <i>vs</i> interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial
Lara D. Veeken·2024· 7 citedOpen Access
Influencers of Achievement of Remission and Low Disease Activity in Response to Disease-Modifying Antirheumatic Drugs (DMARDs) in Patients With Rheumatoid Arthritis
Cureus·2024· 1 citedOpen Access
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2024
British Journal of Dermatology·2024· 10 cited
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2024
Lara D. Veeken·2024· 4 citedOpen Access
Pain Reduction With Oral Methotrexate in Knee Osteoarthritis
Annals of Internal Medicine·2024· 30 citedOpen Access
Patients with High Baseline Neutrophil-to-Lymphocyte Ratio Exhibit Better Response to Filgotinib as Treatment for Rheumatoid Arthritis
Rheumatology and Therapy·2024· 2 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Steven W. Edwards(16), Helen L. Wright(9), Stefano Bombardieri(8), Costantino Pitzalis(8), Nagui Gendi(7), Paul Emery(7), R C Bucknall(5), Simon Bowman(5), Wan‐Fai Ng(5), Colin Pease(5), Nurhan Sutcliffe(5), Peter Lanyon(5), Andrew Cross(5), Bhaskar Dasgupta(4), John D. Isaacs(4), Ian Giles(4), Frances Humby(3), Patrick Durez(3), Myles Lewis(3), Felice Rivellese(3)